• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种含有无活性2A蛋白酶的脊髓灰质炎病毒微型复制子在痘苗病毒感染的细胞中表达。

A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.

作者信息

Pal-Ghosh R, Morrow C D

机构信息

Department of Microbiology, University of Alabama, Birmingham 35294-0007.

出版信息

J Virol. 1993 Aug;67(8):4621-9. doi: 10.1128/JVI.67.8.4621-4629.1993.

DOI:10.1128/JVI.67.8.4621-4629.1993
PMID:8392603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC237847/
Abstract

It has been difficult to evaluate the role of individual viral proteins in poliovirus replication because a suitable complementation system has not yet been developed. To approach this problem, we constructed a chimeric human immunodeficiency virus type 2 (HIV-2)-gag-poliovirus minireplicon in which regions of the gag gene of HIV-2 were inserted in the poliovirus genome between nucleotides 1174 and 2470. Transfection of this chimeric RNA into HeLa cells results in the replication of the minireplicon and expression of an HIV-2-gag-P1 fusion protein which can be immunoprecipitated with antibodies to HIV-2-gag. Expression of the HIV-2-gag-P1 fusion protein was dependent on replication of the chimeric RNA genome. Although the chimeric HIV-2-gag-poliovirus RNA genome replicated in poliovirus-infected cells, transfection of the chimeric HIV-2-gag-poliovirus genome into vaccinia virus-infected cells resulted in increased replication as measured by analysis of chimeric RNA. The increase in replication correlated with an increase in the expression of the HIV-2-gag-P1 fusion protein in vaccinia virus-infected cells. To characterize this system, we constructed a mutation in the 2A gene to change a cysteine at amino acid 109 to a serine. Expression of the HIV-2-gag-P1 fusion protein was not detected when the HIV-2-gag-poliovirus genome containing the 2A mutation was transfected into HeLa cells, demonstrating the mutation was lethal for replication. When the chimeric genome was transfected into poliovirus-infected cells, no RNA replication or expression of the HIV-2-gag-P1 fusion protein was observed. In contrast, transfection of this genome into vaccinia virus-infected cells resulted in replication of the chimeric RNA and expression of two proteins with larger molecular masses than the HIV-2-gag-P1 proteins, possibly representing HIV-2-gag-P1-2A and HIV-2-gag-P1-2ABC fusion proteins. The transfection of the chimeric HIV-2-gag-poliovirus genome containing the 2A mutation into poliovirus-vaccinia virus coinfected cells resulted in the expression and partial processing of the two larger HIV-2-gag-P1 fusion proteins to give the correct molecular mass for the HIV-2-gag-P1 fusion protein. The 2A mutation was reconstructed back into the full-length infectious cDNA of poliovirus. Transfection of this cDNA into vaccinia virus-infected cells followed by immunoprecipitation with anticapsid antibodies demonstrated the presence of two proteins with molecular masses larger than P1, possibly P1-2A and P1-2ABC fusion proteins.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

由于尚未开发出合适的互补系统,因此很难评估个别病毒蛋白在脊髓灰质炎病毒复制中的作用。为了解决这个问题,我们构建了一种嵌合型人类免疫缺陷病毒2型(HIV-2)-gag-脊髓灰质炎病毒微型复制子,其中HIV-2的gag基因区域插入到脊髓灰质炎病毒基因组中核苷酸1174和2470之间。将这种嵌合RNA转染到HeLa细胞中会导致微型复制子的复制以及HIV-2-gag-P1融合蛋白的表达,该融合蛋白可用抗HIV-2-gag抗体进行免疫沉淀。HIV-2-gag-P1融合蛋白的表达依赖于嵌合RNA基因组的复制。尽管嵌合的HIV-2-gag-脊髓灰质炎病毒RNA基因组在脊髓灰质炎病毒感染的细胞中复制,但将嵌合的HIV-2-gag-脊髓灰质炎病毒基因组转染到痘苗病毒感染的细胞中,通过嵌合RNA分析测量显示复制增加。复制的增加与痘苗病毒感染细胞中HIV-2-gag-P1融合蛋白表达的增加相关。为了表征该系统,我们在2A基因中构建了一个突变,将氨基酸109处的半胱氨酸变为丝氨酸。当将含有2A突变的HIV-2-gag-脊髓灰质炎病毒基因组转染到HeLa细胞中时,未检测到HIV-2-gag-P1融合蛋白的表达,这表明该突变对复制是致命的。当嵌合基因组转染到脊髓灰质炎病毒感染的细胞中时,未观察到RNA复制或HIV-2-gag-P1融合蛋白的表达。相反,将该基因组转染到痘苗病毒感染的细胞中会导致嵌合RNA的复制以及两种分子量比HIV-2-gag-P1蛋白更大的蛋白质的表达,可能代表HIV-2-gag-P1-2A和HIV-2-gag-P1-2ABC融合蛋白。将含有2A突变的嵌合HIV-2-gag-脊髓灰质炎病毒基因组转染到脊髓灰质炎病毒-痘苗病毒共感染的细胞中会导致两种较大的HIV-2-gag-P1融合蛋白的表达和部分加工,从而产生正确分子量的HIV-2-gag-P1融合蛋白。2A突变被重建回脊髓灰质炎病毒的全长感染性cDNA中。将该cDNA转染到痘苗病毒感染的细胞中,然后用抗衣壳抗体进行免疫沉淀,结果显示存在两种分子量大于P1的蛋白质,可能是P1-2A和P1-2ABC融合蛋白。(摘要截短至400字)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/ddf37559425a/jvirol00029-0183-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/427d6430da09/jvirol00029-0180-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/d9bcb1f2c15a/jvirol00029-0180-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/06ed0cb2a001/jvirol00029-0181-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/61d3fdb66bc8/jvirol00029-0182-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/2f9158ffe22a/jvirol00029-0182-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/70aeba58fa7a/jvirol00029-0183-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/ddf37559425a/jvirol00029-0183-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/427d6430da09/jvirol00029-0180-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/d9bcb1f2c15a/jvirol00029-0180-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/06ed0cb2a001/jvirol00029-0181-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/61d3fdb66bc8/jvirol00029-0182-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/2f9158ffe22a/jvirol00029-0182-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/70aeba58fa7a/jvirol00029-0183-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/237847/ddf37559425a/jvirol00029-0183-b.jpg

相似文献

1
A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.一种含有无活性2A蛋白酶的脊髓灰质炎病毒微型复制子在痘苗病毒感染的细胞中表达。
J Virol. 1993 Aug;67(8):4621-9. doi: 10.1128/JVI.67.8.4621-4629.1993.
2
Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.一种表达无活性2A蛋白酶的脊髓灰质炎病毒复制子的衣壳化及连续传代
J Virol. 1995 Feb;69(2):1359-66. doi: 10.1128/JVI.69.2.1359-1366.1995.
3
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.通过使用反式提供P1衣壳蛋白的互补系统,对编码完整人类免疫缺陷病毒1型gag基因的脊髓灰质炎病毒复制子进行衣壳化。
J Virol. 1995 Mar;69(3):1548-55. doi: 10.1128/JVI.69.3.1548-1555.1995.
4
Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.感染后表达1型人类免疫缺陷病毒Gag和Pol蛋白的基因工程脊髓灰质炎病毒微型复制子的衣壳化。
J Virol. 1993 Jul;67(7):3712-9. doi: 10.1128/JVI.67.7.3712-3719.1993.
5
Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.来自嵌合HIV-1-脊髓灰质炎病毒微型复制子的人类免疫缺陷病毒1型(HIV-1)gag、pol和env蛋白的表达
J Virol. 1991 Jun;65(6):2875-83. doi: 10.1128/JVI.65.6.2875-2883.1991.
6
Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.由于蛋白酶2A对载体的抑制作用,痘苗病毒重组体对脊髓灰质炎病毒的表达有限。
J Virol. 1990 Mar;64(3):1388-93. doi: 10.1128/JVI.64.3.1388-1393.1990.
7
Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions.微小核糖核酸病毒2A(pro)蛋白分析:蛋白酶与翻译及复制功能的分离
J Virol. 1995 Dec;69(12):7445-52. doi: 10.1128/JVI.69.12.7445-7452.1995.
8
The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage.脊髓灰质炎病毒蛋白酶2A(pro)的C末端残基对病毒RNA复制至关重要,但对顺式或反式蛋白水解切割并非如此。
J Gen Virol. 2001 Feb;82(Pt 2):397-408. doi: 10.1099/0022-1317-82-2-397.
9
Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.一种重组痘苗病毒对脊髓灰质炎病毒缺陷基因组的互补作用,该重组痘苗病毒在反式作用下提供脊髓灰质炎病毒P1衣壳前体。
J Virol. 1993 Jun;67(6):3684-90. doi: 10.1128/JVI.67.6.3684-3690.1993.
10
Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.源自具有谷氨酰胺 - 缬氨酸切割位点的P1前体的脊髓灰质炎病毒衣壳蛋白在组装和RNA包裹方面存在缺陷。
J Virol. 1993 Dec;67(12):7284-97. doi: 10.1128/JVI.67.12.7284-7297.1993.

引用本文的文献

1
Identification of LTR-specific small non-coding RNA in FeLV infected cells.在感染猫白血病病毒的细胞中鉴定长末端重复序列(LTR)特异性小非编码RNA。
FEBS Lett. 2009 Apr 17;583(8):1386-90. doi: 10.1016/j.febslet.2009.03.056. Epub 2009 Mar 29.
2
Cytoplasmic expression of mRNAs containing the internal ribosome entry site and 3' noncoding region of hepatitis C virus: effects of the 3' leader on mRNA translation and mRNA stability.含有丙型肝炎病毒内部核糖体进入位点和3'非编码区的mRNA的细胞质表达:3'前导序列对mRNA翻译和mRNA稳定性的影响。
J Virol. 2002 Dec;76(24):12457-62. doi: 10.1128/jvi.76.24.12457-12462.2002.
3
A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression.

本文引用的文献

1
Systematic nomenclature of picornavirus proteins.小核糖核酸病毒蛋白的系统命名法。
J Virol. 1984 Jun;50(3):957-9. doi: 10.1128/JVI.50.3.957-959.1984.
2
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals.通过SV40转录和复制信号,从克隆的cDNA产生感染性脊髓灰质炎病毒的效率显著提高。
Nucleic Acids Res. 1984 Jun 25;12(12):5123-41. doi: 10.1093/nar/12.12.5123.
3
Poliovirus-induced inhibition of host-cell protein synthesis.脊髓灰质炎病毒引起的宿主细胞蛋白质合成抑制。
一种可诱导表达脊髓灰质炎病毒2A(蛋白酶)的稳定海拉细胞系:对细胞和病毒基因表达的影响
J Virol. 2000 Mar;74(5):2383-92. doi: 10.1128/jvi.74.5.2383-2392.2000.
4
Poliovirus-encoded protease 2APro cleaves the TATA-binding protein but does not inhibit host cell RNA polymerase II transcription in vitro.脊髓灰质炎病毒编码的蛋白酶2APro可切割TATA结合蛋白,但在体外不抑制宿主细胞RNA聚合酶II转录。
J Virol. 1997 Sep;71(9):6881-6. doi: 10.1128/JVI.71.9.6881-6886.1997.
5
Replication of hepatitis A viruses with chimeric 5' nontranslated regions.具有嵌合5'非翻译区的甲型肝炎病毒的复制
J Virol. 1996 May;70(5):2861-8. doi: 10.1128/JVI.70.5.2861-2868.1996.
6
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.通过使用反式提供P1衣壳蛋白的互补系统,对编码完整人类免疫缺陷病毒1型gag基因的脊髓灰质炎病毒复制子进行衣壳化。
J Virol. 1995 Mar;69(3):1548-55. doi: 10.1128/JVI.69.3.1548-1555.1995.
7
Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.一种表达无活性2A蛋白酶的脊髓灰质炎病毒复制子的衣壳化及连续传代
J Virol. 1995 Feb;69(2):1359-66. doi: 10.1128/JVI.69.2.1359-1366.1995.
8
Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations.脊髓灰质炎病毒2C和3D蛋白对致死突变拯救的互补活性低效。
J Virol. 1995 Jul;69(7):4245-54. doi: 10.1128/JVI.69.7.4245-4254.1995.
9
Theiler's virus as a vector for foreign gene delivery.作为外源基因递送载体的泰勒氏病毒。
J Virol. 1995 May;69(5):3171-5. doi: 10.1128/JVI.69.5.3171-3175.1995.
10
A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.一种无法切割3CD的脊髓灰质炎病毒2A(pro)突变体表现出低效的病毒蛋白合成和反式激活缺陷。
J Virol. 1995 Oct;69(10):6280-8. doi: 10.1128/JVI.69.10.6280-6288.1995.
Cell. 1982 Mar;28(3):435-6. doi: 10.1016/0092-8674(82)90195-7.
4
Cloned poliovirus complementary DNA is infectious in mammalian cells.克隆的脊髓灰质炎病毒互补DNA在哺乳动物细胞中具有感染性。
Science. 1981 Nov 20;214(4523):916-9. doi: 10.1126/science.6272391.
5
Primary structure, gene organization and polypeptide expression of poliovirus RNA.脊髓灰质炎病毒RNA的一级结构、基因组织及多肽表达
Nature. 1981 Jun 18;291(5816):547-53. doi: 10.1038/291547a0.
6
Production of single-stranded plasmid DNA.单链质粒DNA的制备。
Methods Enzymol. 1987;153:3-11. doi: 10.1016/0076-6879(87)53044-0.
7
ompT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification.ompT编码大肠杆菌外膜蛋白酶,该酶在纯化过程中可切割T7 RNA聚合酶。
J Bacteriol. 1988 Mar;170(3):1245-53. doi: 10.1128/jb.170.3.1245-1253.1988.
8
Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.脊髓灰质炎病毒P1衣壳蛋白前体体外切割所需的加工决定因素。
J Virol. 1987 Oct;61(10):3181-9. doi: 10.1128/JVI.61.10.3181-3189.1987.
9
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.脊髓灰质炎病毒蛋白酶2A诱导真核起始因子4F多肽p220的裂解。
J Virol. 1987 Sep;61(9):2711-8. doi: 10.1128/JVI.61.9.2711-2718.1987.
10
Regulation of translation by poliovirus.脊髓灰质炎病毒对翻译的调控
Adv Virus Res. 1987;33:175-204. doi: 10.1016/s0065-3527(08)60318-8.